Incannex Healthcare Inc. Common Stock (IXHL)
Stock · NASDAQ · Health Care
$3.64as of 8/28/2026
Price chart
Open in TradingViewActive signals
About IXHL
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treat…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 12
- Website
- www.incannex.com
Fundamentals
- 1-day range
- $3.59$3.79
- Market cap
- $35.06M
- P/E (trailing)
- —
- P/E (forward)
- -2.10
- EPS (trailing)
- $-12.90
- Dividend yield
- —
- Beta
- 1.86
- Avg. volume
- 200.2K
How Incannex Healthcare Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Sep 29, 2025 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
Incannex Healthcare Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- IXHLIncannex Healthcare Inc. Common Stock$3.61▼ 2.17%Market cap $35.06MP/E —$2.49$20.64
- ENLVEnlivex Ltd. Ordinary Shares$1.35▼ 8.47%Market cap $36.53MP/E 0.02$1.35$27.15
- LTRNLantern Pharma Inc. Common Stock$2.08▼ 3.70%Market cap $33.30MP/E —$1.11$4.7
- APLMApollomics Inc. Class A Ordinary Shares$26.6▲ 1.14%Market cap $37.33MP/E —$3.66$42.12
- NNVCNanoViricides Inc. Common Stock$1.24▼ 3.12%Market cap $39.37MP/E —$0.85$2.23
- HYPDHyperion DeFi Inc. Common Stock$3.25▼ 10.36%Market cap $40.32MP/E —$2.34$15
- BCTXBriaCell Therapeutics Corp. Common Shares$3.73▲ 0.54%Market cap $29.23MP/E —$3.68$20.4
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| IXHL Incannex Healthcare Inc. Common Stock | $35.06M | — | $3.61 | ▼ 2.17% | $2.49$20.64 |
| ENLV Enlivex Ltd. Ordinary Shares | $36.53M | 0.02 | $1.35 | ▼ 8.47% | $1.35$27.15 |
| LTRN Lantern Pharma Inc. Common Stock | $33.30M | — | $2.08 | ▼ 3.70% | $1.11$4.7 |
| APLM Apollomics Inc. Class A Ordinary Shares | $37.33M | — | $26.6 | ▲ 1.14% | $3.66$42.12 |
| NNVC NanoViricides Inc. Common Stock | $39.37M | — | $1.24 | ▼ 3.12% | $0.85$2.23 |
| HYPD Hyperion DeFi Inc. Common Stock | $40.32M | — | $3.25 | ▼ 10.36% | $2.34$15 |
| BCTX BriaCell Therapeutics Corp. Common Shares | $29.23M | — | $3.73 | ▲ 0.54% | $3.68$20.4 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Incannex Healthcare Announces First Patient Dosed In Phase 2 DReAMzz Dose-Optimization Study Of IHL-42X In Obstructive Sleep Apnea Across 14 U.S. Sitesbenzinga · 8/25/2026
- Incannex Healthcare Receives Final A$5.1M R&D Tax Incentive Refund Following Approval Of Its Overseas Findings And Amendment Of Its FY25 Tax ReturnBenzinga · 8/11/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 1.29M
- Total value held
- $3.82M
- Institutional holders
- 19
- Unknown625.0K
- Unknown162.9K
- Unknown149.9K
- Unknown104.1K
- Unknown73.2K
- Unknown71.2K
- Unknown40.4K
- Unknown24.5K
- Unknown16.2K
- Unknown12.1K
See the full, filterable feed with live charts on the MarketWall dashboard.